Revvity | PKI - Stock


Revvity reported $387.5M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Agilent USD 1.09B 30M Mar/2026
Align Technology USD 214.94M 11.4M Mar/2026
Bio Techne USD 201.18M 4.27M Mar/2026
Bio-Rad Laboratories USD 770.5M 29.8M Mar/2026
Bruker USD 1.12B 26.9M Mar/2026
Celltrion KRW 126B 3.06B Mar/2026
Charles River Laboratories USD 359.72M 60.62M Mar/2026
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Danaher USD 2.61B 119M Mar/2026
Dentsply International USD 659M 17M Mar/2026
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Illumina USD 611M 47M Mar/2026
Intuitive Surgical USD 1.95B 105.1M Mar/2026
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Laboratory Of America USD 497.7M 37M Mar/2026
Medical Developments International AUD 9.45M 679K Jun/2025
Mesa Laboratories USD 26.56M 1.18M Dec/2025
Mettler Toledo International USD 404.83M 17.6M Mar/2026
Myriad Genetics USD 27.9M 2.7M Mar/2026
OraSure Technologies USD 30.31M 753K Mar/2026
Organigram Holdings CAD 135.16M 2.45M Mar/2026
Pacific Biosciences Of California USD 51.02M 1.74M Mar/2026
Pharma Mar EUR 53.12M 2.48M Mar/2026
Qiagen NV USD 301.89M 11.66M Dec/2025
Quest Diagnostics USD 225M 36M Mar/2026
Quidel USD 611.5M 33.9M Mar/2026
Repligen USD 179.26M 8.8M Mar/2026
Revvity USD 387.5M 8.01M Mar/2026
Sartorius EUR 827.1M 34.9M Mar/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Tilray USD 282.79M 11.9M Jun/2025
Waters USD 1.5B 923.63M Mar/2026
Zealand Pharma A/S 10.7M 9.9M Dec/2024
Zz Pientze Pharmaceu CNY 6.28B 553.86M Mar/2026